Back to School: How biopharma can reboot drug development. Access exclusive analysis here

NEPA: Phase III data

Top-line data from the double-blind, international Phase III NETU-08-18 trial in 1,455 chemotherapy-naïve patients receiving anthracycline-based chemotherapy showed that a single dose of oral NEPA plus dexamethasone was superior to a single dose of oral palonosetron plus dexamethasone on the

Read the full 406 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers